Literature DB >> 29574718

Compromised regulation of the collecting duct ENaC activity in mice lacking AT1a receptor.

Mykola Mamenko1,2, Oleg Zaika1, Viktor Tomilin1, V Behrana Jensen3, Oleh Pochynyuk1.   

Abstract

ENaC-mediated sodium reabsorption in the collecting duct (CD) is a critical determinant of urinary sodium excretion. Existing evidence suggest direct stimulatory actions of Angiotensin II (Ang II) on ENaC in the CD, independently of the aldosterone-mineralocorticoid receptor (MR) signaling. Deletion of the major renal AT1 receptor isoform, AT1a R, decreases blood pressure and reduces ENaC abundance despite elevated aldosterone levels. The mechanism of this insufficient compensation is not known. Here, we used patch clamp electrophysiology in freshly isolated split-opened CDs to investigate how AT1a R dysfunction compromises functional ENaC activity and its regulation by dietary salt intake. Ang II had no effect on ENaC activity in CDs from AT1a R -/- mice suggesting no complementary contribution of AT2 receptors. We next found that AT1a R deficient mice had lower ENaC activity when fed with low (<0.01% Na+ ) and regular (0.32% Na+ ) but not with high (∼2% Na+ ) salt diet, when compared to the respective values obtained in Wild type (WT) animals. Inhibition of AT1 R with losartan in wild-type animals reproduces the effects of genetic ablation of AT1a R on ENaC activity arguing against contribution of developmental factors. Interestingly, manipulation with aldosterone-MR signaling via deoxycosterone acetate (DOCA) and spironolactone had much reduced influence on ENaC activity upon AT1a R deletion. Consistently, AT1a R -/- mice have a markedly diminished MR abundance in cytosol. Overall, we conclude that AT1a R deficiency elicits a complex inhibitory effect on ENaC activity by attenuating ENaC Po and precluding adequate compensation via aldosterone cascade due to decreased MR availability.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mas; Na+ reabsorption; aldosterone; distal renal tubule; mineralocorticoid receptors

Mesh:

Substances:

Year:  2018        PMID: 29574718      PMCID: PMC6301083          DOI: 10.1002/jcp.26552

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  45 in total

1.  Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney.

Authors:  Peng Sun; Peng Yue; Wen-Hui Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

2.  Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats.

Authors:  Micheline Monteiro de Resende; Katalin Kauser; José Geraldo Mill
Journal:  Life Sci       Date:  2006-01-18       Impact factor: 5.037

3.  The renal TRPV4 channel is essential for adaptation to increased dietary potassium.

Authors:  Mykola V Mamenko; Nabila Boukelmoune; Viktor N Tomilin; Oleg L Zaika; V Behrana Jensen; Roger G O'Neil; Oleh M Pochynyuk
Journal:  Kidney Int       Date:  2017-02-07       Impact factor: 10.612

4.  Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II.

Authors:  M I Oliverio; C F Best; O Smithies; T M Coffman
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

Review 5.  The ENaC channel as the primary determinant of two human diseases: Liddle syndrome and pseudohypoaldosteronism.

Authors:  L Schild
Journal:  Nephrologie       Date:  1996

6.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.

Authors:  János Peti-Peterdi; David G Warnock; P Darwin Bell
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

7.  Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney.

Authors:  S Masilamani; G H Kim; C Mitchell; J B Wade; M A Knepper
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Aberrant ENaC activation in Dahl salt-sensitive rats.

Authors:  Yutaka Kakizoe; Kenichiro Kitamura; Takehiro Ko; Naoki Wakida; Ai Maekawa; Taku Miyoshi; Naoki Shiraishi; Masataka Adachi; Zheng Zhang; Shyama Masilamani; Kimio Tomita
Journal:  J Hypertens       Date:  2009-08       Impact factor: 4.844

9.  Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension.

Authors:  Daian Chen; Johannes Stegbauer; Matthew A Sparks; Donald Kohan; Robert Griffiths; Marcela Herrera; Susan B Gurley; Thomas M Coffman
Journal:  Hypertension       Date:  2016-05-02       Impact factor: 10.190

10.  Differential expression of angiotensin receptor 1A and 1B in mouse.

Authors:  J M Burson; G Aguilera; K W Gross; C D Sigmund
Journal:  Am J Physiol       Date:  1994-08
View more
  4 in total

1.  Electrolyte and transporter responses to angiotensin II induced hypertension in female and male rats and mice.

Authors:  Luciana C Veiras; Brandon E McFarlin; Donna L Ralph; Vadym Buncha; Jessica Prescott; Borna S Shirvani; Jillian C McDonough; Darren Ha; Jorge Giani; Susan B Gurley; Mykola Mamenko; Alicia A McDonough
Journal:  Acta Physiol (Oxf)       Date:  2020-02-12       Impact factor: 6.311

2.  PF-06869206 is a selective inhibitor of renal Pi transport: evidence from in vitro and in vivo studies.

Authors:  Linto Thomas; Jianxiang Xue; Viktor N Tomilin; Oleh M Pochynyuk; Jessica A Dominguez Rieg; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-03

3.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09

4.  Epac1-/- and Epac2-/- mice exhibit deficient epithelial Na+ channel regulation and impaired urinary Na+ conservation.

Authors:  Viktor N Tomilin; Kyrylo Pyrshev; Anna Stavniichuk; Naghmeh Hassanzadeh Khayyat; Guohui Ren; Oleg Zaika; Sherif Khedr; Alexander Staruschenko; Fang C Mei; Xiaodong Cheng; Oleh Pochynyuk
Journal:  JCI Insight       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.